| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/31/2007 | US20070124826 Method of differentiation from embryo-stem cell of primate to hematogenous cell |
| 05/31/2007 | US20070123459 IL-17 like molecules and uses thereof |
| 05/31/2007 | US20070123455 Immunomodulatory agents for treatment of inflammatory diseases |
| 05/31/2007 | US20070123448 Novel chemical entities affecting neuroblastoma tumor-initiating cells |
| 05/31/2007 | US20070122906 Method of culturing cells |
| 05/31/2007 | US20070122905 PDX1-expressing dorsal and ventral foregut endoderm |
| 05/31/2007 | US20070122904 Method and apparatus for culturing cells |
| 05/31/2007 | US20070122903 Amniotic fluid derived cells |
| 05/31/2007 | US20070122902 Method for isolating and culturing multipotent progenitor/stem cells from umbilical cord blood and method for inducing differentiation thereof |
| 05/31/2007 | US20070122901 Method of constructing artificial cell tissue and base material therefor |
| 05/31/2007 | US20070122894 Sterile microbiological nutrient media device and methods of using |
| 05/31/2007 | US20070122891 Strain of sorangium cellulosum for generation of epothilone derivatives; antitumor agents |
| 05/31/2007 | US20070122884 Factor VII glycoforms |
| 05/31/2007 | US20070122883 Nucleotide sequences coding orphan receptor component of multimeric complex for use in identifying modulator for prevention and treatment of cell proliferative disorders |
| 05/31/2007 | US20070122881 Rhamnose-inducible expression systems and methods |
| 05/31/2007 | US20070122879 for detecting and treating viral infections in in vitro and in vivo; ligand-binding receptor polypeptides can also be used to block ligand activity in vitro and in vivo; for forming a heterodimeric receptor complex with IL-28R and CRF2-4 |
| 05/31/2007 | US20070122858 Cell-based fluorescence resonance energy transfer (fret) assays for clostridial toxins |
| 05/31/2007 | US20070122851 Novel fluorescent and colored proteins, and polynucleotides that encode these proteins |
| 05/31/2007 | US20070122849 Rhesus monkey P2X7 purinergic receptor and uses thereof |
| 05/31/2007 | US20070122796 Method of preparing basement membrane, method of constructing basement membrane specimen, reconstituted artificial tissue using the basement membrane specimen and process for producing the same |
| 05/31/2007 | US20070122794 Devices and methods for pharmacokinetic-based cell culture system |
| 05/31/2007 | US20070122428 Genetically modified cholera toxin (CT-CRM) comprising reduced toxicity and enhanced immunological response for use in preparation of vaccines against parasitic infection |
| 05/31/2007 | US20070122423 Derp1 and proderp1 allergen derivatives |
| 05/31/2007 | US20070122422 Sodium-independent small neutral amino acid transporter transporting L- and D- amino acids |
| 05/31/2007 | US20070122421 Flagellin fusion for use in generating vaccines for prevention and treatment of tumors, allergens and nervous system disorders |
| 05/31/2007 | US20070122413 Il-21 antagonists |
| 05/31/2007 | US20070122407 ISOLATED NUCLEIC ACIDS, VECTORS AND HOST CELLS ENCODING ErbB3 ANTIBODIES |
| 05/31/2007 | US20070122404 Humanized immunoglobulin reactive with alpha4beta7 integrin |
| 05/31/2007 | US20070122403 Molecules with extended half-lives, compositions and uses thereof |
| 05/31/2007 | US20070122396 Morphogenic proteins and stimulatory factors in gene therapy |
| 05/31/2007 | US20070122394 administering a VEGFR modulating agent that comprises placental growth factor; a growth factor that binds and activates Flt-1 such as PIGF or VEGF-B, an anti-Flt-1 agonistic antibody or a small molecule agonist |
| 05/31/2007 | US20070122393 Immunophenotype and immunogenicity of human adipose derived cells |
| 05/31/2007 | US20070122392 Propagation of undifferentiated embryonic stem cells in hyaluronic acid hydrogel |
| 05/31/2007 | US20070122391 Compositions and methods for non-targeted activation of endogenous genes |
| 05/31/2007 | US20070122389 Stage specific follicle maturation systems |
| 05/31/2007 | US20070122387 Hair grafts derived from plucked hair |
| 05/31/2007 | US20070122386 Preparation method of a hair dermal papilla cell preparation, composition and method for regenerating hair follicles, and animal having regenerated hair follicles |
| 05/31/2007 | CA2632370A1 Serum-free expansion of cells in culture |
| 05/31/2007 | CA2632052A1 Biomarkers and methods for identification of agents useful in the treatment of affective disorders |
| 05/31/2007 | CA2631172A1 Use of type ii pneumocytes in the treatment of pulmonary diseases associated with pulmonary fibrosis |
| 05/31/2007 | CA2631015A1 Human monoclonal antibody human cd134 (ox40) and methods of making and using same |
| 05/31/2007 | CA2631013A1 Activin-actriia antagonists and uses for promoting bone growth |
| 05/31/2007 | CA2630964A1 Antibody treatment of alzheimer's and related diseases |
| 05/31/2007 | CA2630770A1 Recombinant polyvalent vaccine |
| 05/31/2007 | CA2630652A1 Bioassays |
| 05/31/2007 | CA2629551A1 Multipotent neural stem cells |
| 05/31/2007 | CA2628530A1 Novel stem cells, nucleotide sequences and proteins therefrom |
| 05/31/2007 | CA2628126A1 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 05/30/2007 | EP1790731A2 Process for the production of delta 5-unsaturated fatty acids in transgenic organisms |
| 05/30/2007 | EP1790728A2 Imaging, diagnosis and treatment of disease |
| 05/30/2007 | EP1790727A2 Proteins and nucleic acids encoding same |
| 05/30/2007 | EP1790726A2 Modified and stabilized GDF propeptides and uses thereof |
| 05/30/2007 | EP1790725A2 Proteins named after FCTRX and nucleic acids encoding same |
| 05/30/2007 | EP1790724A1 Knockout nonhuman animal |
| 05/30/2007 | EP1790720A1 Polypeptide having activity of unsaturating omega3-fatty acid, polynucleotide coding for the polypeptide and use thereof |
| 05/30/2007 | EP1790717A2 Compositions and methods for the identification of lung tumor cells |
| 05/30/2007 | EP1790716A1 Uses of the FcRn receptor |
| 05/30/2007 | EP1790664A1 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 05/30/2007 | EP1790663A1 Monoclonal antibody(ad5-10) against tumor necrosis factor-related apoptosis-inducing ligand receptor dr5, the producing method and uses thereof |
| 05/30/2007 | EP1790662A1 Nucleic acid and corresponding protein entitled 121P2A3 useful in treatment and detection of cancer |
| 05/30/2007 | EP1790661A2 A highly efficient secretory signal peptide and a protein expression system using the peptide thereof |
| 05/30/2007 | EP1790659A2 Polypeptides of pseudomonas aeruginosa |
| 05/30/2007 | EP1790655A2 Biologically active peptides |
| 05/30/2007 | EP1789571A1 Production of polypeptides |
| 05/30/2007 | EP1789556A1 Polypeptides of botryosphaeria rhodina |
| 05/30/2007 | EP1789555A1 Novel regulation protein |
| 05/30/2007 | EP1789552A2 Methods of regulating differentiation and treating of multiple myeloma |
| 05/30/2007 | EP1789540A1 Non-embryonic totipotent blastomer-like stem cells and methods therefor |
| 05/30/2007 | EP1789539A2 Promoter molecules for use in plants |
| 05/30/2007 | EP1789538A2 Conditioned medium of autologous or allogenic progenitor cells for angiogenesis treatment |
| 05/30/2007 | EP1789537A2 Conditioned medium comprissing wnt proteins to promote repair of damaged tissue |
| 05/30/2007 | EP1789536A2 Cultured three dimensional tissues and uses thereof |
| 05/30/2007 | EP1789535A2 Use of pax4 in pancreatic cell proliferation |
| 05/30/2007 | EP1789534A1 Isolation of stem/progenitor cells from amniotic membrane of umbilical cord. |
| 05/30/2007 | EP1789449A1 Anti-glycated cd59 antibodies and uses thereof |
| 05/30/2007 | EP1789441A2 Notch mutations leading to increased receptor signaling |
| 05/30/2007 | EP1789437A1 Npc1l1 and npc1l1 inhibitors and methods of use thereof |
| 05/30/2007 | EP1789435A1 A method for production of mature natural killer cell |
| 05/30/2007 | EP1789104A1 Jaw bone augmentation using tooth primordium |
| 05/30/2007 | EP1789089A2 Compositions and treatments using ex vivo activated cells for myelosuppressed patients |
| 05/30/2007 | EP1789063A2 Tissue engineered meat for consumption and a method for producing tissue engineered meat for consumption |
| 05/30/2007 | EP1788974A1 Method of evaluating biological material and bioreactor therefor |
| 05/30/2007 | EP1576134A4 Method for discovering neurogenic agents |
| 05/30/2007 | EP1530648B1 Methods and device for decarbonising a steel melt |
| 05/30/2007 | EP1506235B1 Method for producing monoclonal antibodies |
| 05/30/2007 | EP1311663B1 Claudin polypeptides |
| 05/30/2007 | EP1171165B1 Intramyocardial injection of autologous bone marrow |
| 05/30/2007 | EP0975754B1 Osteoprotegerin binding proteins and receptors |
| 05/30/2007 | EP0904367B1 Scf analog compositions and methods |
| 05/30/2007 | CN1973038A HCV RNA having novel sequence |
| 05/30/2007 | CN1973037A Process for producing dipeptides or dipeptide derivatives |
| 05/30/2007 | CN1973033A Therapeutic reprogramming, hybrid stem cells and maturation |
| 05/30/2007 | CN1973032A Stem cell maturation method for all tissue lines |
| 05/30/2007 | CN1973031A Cells exhibiting neuronal progenitor cell characteristics |
| 05/30/2007 | CN1973030A Dendritic cell obtained by antigen pulsing |
| 05/30/2007 | CN1973029A Nanofibrillar structure and applications including cell and tissue culture |
| 05/30/2007 | CN1970771A Process for high-efficiency production of human lysozyme by using mammary gland of domestic animal |
| 05/30/2007 | CN1970770A Improved production of isoprenoids |
| 05/30/2007 | CN1970767A Plant-related gene from paddy and its coded protein and application thereof |
| 05/30/2007 | CN1970766A Paraquat resistance gene and a vascular tissue- and trichome-specific promoter |